Company Profiles

driven by the PitchBook Platform

Amal Therapeutics

Description

Developer of therapeutic cancer vaccines. The company develops and progresses therapeutic cancer vaccines and therapeutic tumor vaccination.

2012

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$3.05M

Latest Deal Amount

$3.16M

Total Amount Raised

Description

Developer of therapeutic cancer vaccines. The company develops and progresses therapeutic cancer vaccines and therapeutic tumor vaccination.

Website:

www.amaltherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

c/o Fondation pour Recherches Médicales 64 av. de la Roseraie 1205 GenevaSwitzerland
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Amal Therapeutics's full profile, request a free trial.

    Amal Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Amal Therapeutics Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Boehringer Ingelheim Venture FundCorporate Venture CapitalMinority000 0000000 0000
    Commission for Technology and InnovationGovernment000 0000000 0000
    High-Tech GründerfondsVenture CapitalMinority000 0000000 0000
    Venture kickAccelerator/IncubatorMinority000 0000000 0000
    VI PartnersVenture CapitalMinority000 0000000 0000
    Boehringer Ingelheim Venture Fund Corporate Venture Capital
    Commission for Technology and Innovation Government
    High-Tech Gründerfonds Venture Capital
    Venture kick Accelerator/Incubator
    VI Partners Venture Capital

    Amal Therapeutics Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Madiha Derouazi Ph.DFounder & Chief Executive Officer
    Madiha Derouazi Ph.D Founder & Chief Executive Officer

    Amal Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Diego Braguglia Ph.DVI PartnersGeneral Partner000 0000
    Frank Hensel Ph.DHigh-Tech GründerfondsSenior Investment Manager000 0000
    Frank Kalkbrenner MDBoehringer IngelheimBoard Observer000 0000
    Johanna Holldack MDSelfChairman000 0000
    Knut Elbers Ph.DBoehringer IngelheimDirector, Project Manager & Investment Manager000 0000
    Diego Braguglia Ph.D General Partner VI Partners
    Frank Hensel Ph.D Senior Investment Manager High-Tech Gründerfonds
    Frank Kalkbrenner MD Board Observer Boehringer Ingelheim
    Johanna Holldack MD Chairman Self
    Knut Elbers Ph.D Director, Project Manager & Investment Manager Boehringer Ingelheim
    Request full access to PitchBook